Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

WEST PHARMACEUTICAL SERVICES INC Director's Dealing 2006

Feb 28, 2006

30339_dirs_2006-02-28_442f6db1-f72e-4ade-9624-10d2fc634d97.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: WEST PHARMACEUTICAL SERVICES INC ((WST))
CIK: 0000105770
Period of Report: 2006-02-24

Reporting Person: ABBOTT JOSEPH E (Corporate Controller)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2006-02-24 Common Stock A 1586 Acquired 16378.2311 Direct
2006-02-24 Common Stock A 468.2498 $32.5850 Acquired 16846.4809 Direct
2006-02-24 Common Stock A 500 Acquired 17346.4809 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2006-02-24 Stock Option (Right to Buy) $32.5850 A 4641 Acquired 2016-02-24 Common Stock (4641.00) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 2445.3547 Indirect

Footnotes

F1: Bonus and incentive shares granted on 2/24/06.

F2: Additional amount of shares due to achieving above targeted amount for first performance period of 3/7/05 Performance Vested Restricted Share grant.

F3: Reflects additional shares purchased through dividend reinvestments based on most recent plan statement.